Safety of reduced infusion times for nivolumab plus ipilimumab (N + I) and nivolumab alone (N) in advanced melanoma Meeting Abstract
| Authors: | Martin-Algarra, S.; Haanen, J. B.; Horak, C.; Bhatia, S.; Ribas, A.; Hwu, W. J.; Slingluff, C. L.; Sharfman, W. H.; Callahan, M.; Hodi, F. S.; Wolchok, J. D.; Luke, J.; Young, T. C.; Qureshi, A.; Urba, W. J. |
| Abstract Title: | Safety of reduced infusion times for nivolumab plus ipilimumab (N + I) and nivolumab alone (N) in advanced melanoma |
| Meeting Title: | 41st European Society for Medical Oncology Congress (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 27 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2016 Oct 7-11 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2016-10-01 |
| Start Page: | vi385 |
| Language: | English |
| ACCESSION: | WOS:000393913000218 |
| DOI: | 10.1093/annonc/mdw379.20 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1125P -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work